Media Summary: Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, discusses ... Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ... Jeffrey Barrett from the Critical Path Institute provides the overview of this
Midd Training Module 2 Part - Detailed Analysis & Overview
Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, discusses ... Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ... Jeffrey Barrett from the Critical Path Institute provides the overview of this This lecture by Dr. Rajesh Krishna is a case study showing how anti-viral kinetic modeling can be used to support drug ... This lecture by Jeffrey Barrett from the Critical Path Institute describes the This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ...
Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. Dr. Qi Liu, the Assoc. Director for Innovation & Partnership in the Office of Clinical Pharmacology, Office of Translational Sciences ... Dr. Jeff Barrett from the Critical path Institute describes the application of Dr. Mark R. Gasronguay, Founder and CEO of the Metrum Research Group, discusses how to use simulation from a mathematical ... Clinical Pharmacologist Dr. Colin Pillai discusses if there are differences between an industry versus a regulatory setting, or if ...
